|
ZNF461 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.060800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.476390E-02 |
| Normal-vs-Stage2 |
4.182600E-01 |
| Normal-vs-Stage3 |
2.310000E-01 |
| Normal-vs-Stage4 |
1.217940E-02 |
| Stage1-vs-Stage2 |
7.328400E-01 |
| Stage1-vs-Stage3 |
1.021060E-03 |
| Stage1-vs-Stage4 |
2.36899999994655E-06 |
| Stage2-vs-Stage3 |
1.579750E-01 |
| Stage2-vs-Stage4 |
3.340200E-02 |
| Stage3-vs-Stage4 |
2.057600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.844000E-01 |
| Normal-vs-AfricanAmerican |
3.188000E-01 |
| Normal-vs-Asian |
6.433700E-02 |
| Caucasian-vs-AfricanAmerican |
1.659160E-01 |
| Caucasian-vs-Asian |
9.095800E-03 |
| AfricanAmerican-vs-Asian |
2.398100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.582400E-01 |
| Normal-vs-Female |
4.071800E-01 |
| Male-vs-Female |
6.505000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.235800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.996100E-02 |
| Normal-vs-Age(61-80Yrs) |
7.467800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.187600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.822000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.126200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.125800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.138000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.318430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.269600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.083710E-02 |
| Normal-vs-Grade 2 |
5.757700E-03 |
| Normal-vs-Grade 3 |
6.009400E-01 |
| Normal-vs-Grade 4 |
5.68610000000191E-05 |
| Grade 1-vs-Grade 2 |
5.851000E-01 |
| Grade 1-vs-Grade 3 |
3.399700E-02 |
| Grade 1-vs-Grade 4 |
7.88680000000097E-05 |
| Grade 2-vs-Grade 3 |
7.165200E-04 |
| Grade 2-vs-Grade 4 |
5.53279977388854E-10 |
| Grade 3-vs-Grade 4 |
2.646400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.881500E-03 |
| Normal-vs-ccB subtype |
8.287600E-01 |
| ccA subtype-vs-ccB subtype |
2.801400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.005400E-01 |
| Normal-vs-N1 |
5.142100E-02 |
| N0-vs-N1 |
1.437200E-01 |
|
|
